Key Events This Week
16 Mar: Stock plunged to a 52-week and all-time low, hitting the lower circuit at Rs.9.75
18 Mar: Strong buying pressure pushed the stock to the upper circuit at Rs.10.10
20 Mar: Week ended with a modest recovery to Rs.9.95, still below the week’s open

JFL Life Sciences Ltd Surges to Upper Circuit Amid Strong Buying Pressure
2026-03-18 13:00:08JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit price limit on 18 Mar 2026, registering a maximum daily gain of 4.66%. This sharp price movement was driven by robust buying interest, resulting in a regulatory freeze on further trading and highlighting significant unfilled demand in the stock.
Read full news article
JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure
2026-03-16 12:00:16JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 16 Mar 2026, hitting its lower circuit price limit of ₹9.75. The stock recorded a maximum daily loss of 4.88%, underperforming its sector by 3.51% and reflecting intense selling pressure and panic among investors.
Read full news article
JFL Life Sciences Ltd is Rated Sell
2026-03-16 10:10:31JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
JFL Life Sciences Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-03-13 11:00:14Shares of JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged to their lower circuit limit on 13 Mar 2026, closing at ₹10.25, down 4.65% on the day. The stock’s sharp decline reflects intense selling pressure and panic among investors, with volumes and turnover indicating a significant imbalance between supply and demand.
Read full news article
JFL Life Sciences Ltd is Rated Sell
2026-03-05 10:10:37JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
JFL Life Sciences Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-03-05 10:00:20Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 5 Mar 2026, closing at ₹10.45, marking a maximum daily loss of 4.57%. The stock’s sharp decline reflects intense selling pressure and panic among investors, with volumes remaining subdued and supply largely unfilled, signalling a challenging outlook for this micro-cap pharmaceutical player.
Read full news article
JFL Life Sciences Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-02-20 11:00:06Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 20 Feb 2026, closing at ₹10.40, marking a maximum daily loss of 4.59%. The micro-cap pharmaceutical stock faced intense selling pressure, with volumes rising amid panic selling and unfilled supply, signalling deep investor concerns despite the sector’s modest gains.
Read full news article






